These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 30516555)
1. Topical Rho-Associated Kinase Inhibitor, Y27632, Accelerates Corneal Endothelial Regeneration in a Canine Cryoinjury Model. Miyagi H; Kim S; Li J; Murphy CJ; Thomasy SM Cornea; 2019 Mar; 38(3):352-359. PubMed ID: 30516555 [TBL] [Abstract][Full Text] [Related]
2. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing. Okumura N; Koizumi N; Kay EP; Ueno M; Sakamoto Y; Nakamura S; Hamuro J; Kinoshita S Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2493-502. PubMed ID: 23462749 [TBL] [Abstract][Full Text] [Related]
3. Effect of the Rho Kinase Inhibitor Y-27632 on Corneal Endothelial Wound Healing. Okumura N; Inoue R; Okazaki Y; Nakano S; Nakagawa H; Kinoshita S; Koizumi N Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):6067-74. PubMed ID: 26393474 [TBL] [Abstract][Full Text] [Related]
4. Y-27632 Promotes the Repair Effect of Umbilical Cord Blood-Derived Endothelial Progenitor Cells on Corneal Endothelial Wound Healing. Zhang W; Shao C; Yu F; Chen J; Fu Y; Fan X Cornea; 2021 Feb; 40(2):203-214. PubMed ID: 33086282 [TBL] [Abstract][Full Text] [Related]
5. Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing. Okumura N; Okazaki Y; Inoue R; Kakutani K; Nakano S; Kinoshita S; Koizumi N Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1284-92. PubMed ID: 26998714 [TBL] [Abstract][Full Text] [Related]
6. ROCK inhibitor enhances adhesion and wound healing of human corneal endothelial cells. Pipparelli A; Arsenijevic Y; Thuret G; Gain P; Nicolas M; Majo F PLoS One; 2013; 8(4):e62095. PubMed ID: 23626771 [TBL] [Abstract][Full Text] [Related]
7. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue. Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Tsuchiya H; Hamuro J; Kinoshita S Am J Pathol; 2012 Jul; 181(1):268-77. PubMed ID: 22704232 [TBL] [Abstract][Full Text] [Related]
8. New therapeutic modality for corneal endothelial disease using Rho-associated kinase inhibitor eye drops. Koizumi N; Okumura N; Ueno M; Kinoshita S Cornea; 2014 Nov; 33 Suppl 11():S25-31. PubMed ID: 25289721 [TBL] [Abstract][Full Text] [Related]
9. Effect of Rho-kinase Inhibitor, Y27632, on Porcine Corneal Endothelial Cell Culture, Inflammation and Immune Regulation. Lee W; Miyagawa Y; Long C; Zhang M; Cooper DK; Hara H Ocul Immunol Inflamm; 2016 Oct; 24(5):579-93. PubMed ID: 26471144 [TBL] [Abstract][Full Text] [Related]
10. Targeting non-muscle myosin II promotes corneal endothelial migration through regulating lamellipodial dynamics. Ho WT; Chang JS; Chou SF; Hwang WL; Shih PJ; Chang SW; Yang MH; Jou TS; Wang IJ J Mol Med (Berl); 2019 Sep; 97(9):1345-1357. PubMed ID: 31302714 [TBL] [Abstract][Full Text] [Related]
11. The new therapeutic concept of using a rho kinase inhibitor for the treatment of corneal endothelial dysfunction. Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Hamuro J; Kinoshita S Cornea; 2011 Oct; 30 Suppl 1():S54-9. PubMed ID: 21912232 [TBL] [Abstract][Full Text] [Related]
12. Involvement of cyclin D and p27 in cell proliferation mediated by ROCK inhibitors Y-27632 and Y-39983 during corneal endothelium wound healing. Okumura N; Nakano S; Kay EP; Numata R; Ota A; Sowa Y; Sakai T; Ueno M; Kinoshita S; Koizumi N Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):318-29. PubMed ID: 24106120 [TBL] [Abstract][Full Text] [Related]
14. Nicotinamide inhibits corneal endothelial mesenchymal transition and accelerates wound healing. Li Z; Duan H; Li W; Jia Y; Zhang S; Zhao C; Zhou Q; Shi W Exp Eye Res; 2019 Jul; 184():227-233. PubMed ID: 31028751 [TBL] [Abstract][Full Text] [Related]
15. The Role of Rho Kinase Inhibitors in Corneal Endothelial Dysfunction. Okumura N; Kinoshita S; Koizumi N Curr Pharm Des; 2017; 23(4):660-666. PubMed ID: 27917718 [TBL] [Abstract][Full Text] [Related]
16. Corneal Endothelial Cell Migration and Proliferation Enhanced by Rho Kinase (ROCK) Inhibitors in In Vitro and In Vivo Models. Meekins LC; Rosado-Adames N; Maddala R; Zhao JJ; Rao PV; Afshari NA Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6731-6738. PubMed ID: 27951595 [TBL] [Abstract][Full Text] [Related]
17. Effect of a p38 Mitogen-Activated Protein Kinase Inhibitor on Corneal Endothelial Cell Proliferation. Nakahara M; Okumura N; Nakano S; Koizumi N Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4218-4227. PubMed ID: 30128493 [TBL] [Abstract][Full Text] [Related]
18. Effect of Rho-Associated Kinase Inhibitor and Mesenchymal Stem Cell-Derived Conditioned Medium on Corneal Endothelial Cell Senescence and Proliferation. Jung B; Lee H; Kim S; Tchah H; Hwang C Cells; 2021 Jun; 10(6):. PubMed ID: 34207965 [TBL] [Abstract][Full Text] [Related]
19. TSG-6 protects corneal endothelium from transcorneal cryoinjury in rabbits. Kim JA; Ko JH; Ko AY; Lee HJ; Kim MK; Wee WR; Lee RH; Fulcher SF; Oh JY Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4905-12. PubMed ID: 25034606 [TBL] [Abstract][Full Text] [Related]
20. Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal models. Koizumi N; Okumura N; Kinoshita S Exp Eye Res; 2012 Feb; 95(1):60-7. PubMed ID: 22067130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]